The majority of uptake studies in vitro have been performed in buffers devoid of protein.
In spite of their prolific growth ability in vivo, attempts to proliferate adult hepatocytes in vitro have been less successful.
Numerous attempts to shape a new esophagus in vitro have been described in the last decade.
Antioxidant and anti-tumor activities in vitro have been studied by DPPH, ABTS, reducing power assay, and MTT assay, respectively.
The QCM units [36] and associated software (Vitrocell Systems, Waldkirch, Germany) utilised for quantification of smoke particle deposition in vitro have been previously published [22].
Parameters affecting the release kinetics in vitro have been studied in order to design specific release profiles suitable for direct intra-tumoral injection.
Although attempts to create microvasculature in vitro have been described previously (Microcirculation 2 19955), 377; Tissue Eng. 6 (2000), 105; Ann.
Mechanical stresses and strains on cardiovascular cells in vitro have been recognised and can be measured by a culture force monitor.
However, small molecules that directly target the most common misfolded CFTR mutant, F508del, and improve its intracellular trafficking in vitro, have been less effective than expected when tested in CF patients, even in combination with Ivacaftor.
Marketed chemical spermicides, which show some activity against sexually transmitted pathogens in vitro, have been evaluated as topical microbicides.
Human topoII isoforms α and β, while enzymatically similar in vitro, have been shown to have different cellular roles.
